BCRX vs NDSN · rev $374.7M vs P/E 31, rev $817.7M
BioCryst Pharmaceuticals Inc (BCRX) versus Nordson Corporation (NDSN) — a side-by-side from cached financials, not a winner call.
BioCryst Pharmaceuticals Inc (BCRX) is a drug manufacturers - specialty & generic company listed on US.
Nordson Corporation (NDSN) is a specialty industrial machinery company listed on NASDAQ.
Latest reported BCRX revenue for 2026-06-30 was $374.7M. Net income was -$643.4M. BCRX currently screens at market cap $1.83B.
Latest reported NDSN revenue for 2026-07-31 was $817.7M. Net income was $152.8M. Revenue was down 42.0% from 2026-04-30 to 2026-07-31. NDSN currently screens at market cap $16.17B and trailing P/E 31.0.
BCRX currently screens at market cap $1.83B. NDSN currently screens at market cap $16.17B and trailing P/E 31.0.
Not investment advice. Open the BCRX and NDSN stock pages for the full models.
Not investment advice.